These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33859210)

  • 1. Botulinum toxin injection changes resting state cerebellar connectivity in cervical dystonia.
    Hok P; Hvizdošová L; Otruba P; Kaiserová M; Trnečková M; Tüdös Z; Hluštík P; Kaňovský P; Nevrlý M
    Sci Rep; 2021 Apr; 11(1):8322. PubMed ID: 33859210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in sensorimotor network activation after botulinum toxin type A injections in patients with cervical dystonia: a functional MRI study.
    Nevrlý M; Hluštík P; Hok P; Otruba P; Tüdös Z; Kaňovský P
    Exp Brain Res; 2018 Oct; 236(10):2627-2637. PubMed ID: 29971454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain connectivity abnormalities and treatment-induced restorations in patients with cervical dystonia.
    Feng L; Yin D; Wang X; Xu Y; Xiang Y; Teng F; Pan Y; Zhang X; Su J; Wang Z; Jin L
    Eur J Neurol; 2021 May; 28(5):1537-1547. PubMed ID: 33350546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Task-free functional MRI in cervical dystonia reveals multi-network changes that partially normalize with botulinum toxin.
    Delnooz CC; Pasman JW; Beckmann CF; van de Warrenburg BP
    PLoS One; 2013; 8(5):e62877. PubMed ID: 23650536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensorimotor Perceptive Rehabilitation Integrated (SPRInt) program: exercises with augmented movement feedback associated to botulinum neurotoxin in idiopathic cervical dystonia-an observational study.
    Castagna A; Caronni A; Crippa A; Sciumè L; Giacobbi G; Corrini C; Montesano A; Ramella M
    Neurol Sci; 2020 Jan; 41(1):131-138. PubMed ID: 31478151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized botulinum toxin type A therapy for cervical dystonia based on kinematic guidance.
    Samotus O; Lee J; Jog M
    J Neurol; 2018 Jun; 265(6):1269-1278. PubMed ID: 29557988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia.
    Hu W; Rundle-Gonzalez V; Kulkarni SJ; Martinez-Ramirez D; Almeida L; Okun MS; Wagle Shukla A
    Parkinsonism Relat Disord; 2019 Jun; 63():195-198. PubMed ID: 30837195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical utility of botulinum toxin injections targeted at the motor endplate zone in cervical dystonia.
    Delnooz CC; Veugen LC; Pasman JW; Lapatki BG; van Dijk JP; van de Warrenburg BP
    Eur J Neurol; 2014 Dec; 21(12):1486-e98. PubMed ID: 25060697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.
    Brashear A; Lew MF; Dykstra DD; Comella CL; Factor SA; Rodnitzky RL; Trosch R; Singer C; Brin MF; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M
    Neurology; 1999 Oct; 53(7):1439-46. PubMed ID: 10534248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.
    Brin MF; Lew MF; Adler CH; Comella CL; Factor SA; Jankovic J; O'Brien C; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M
    Neurology; 1999 Oct; 53(7):1431-8. PubMed ID: 10534247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic cortical gray matter volume changes after botulinum toxin in cervical dystonia.
    Delnooz CC; Pasman JW; van de Warrenburg BP
    Neurobiol Dis; 2015 Jan; 73():327-33. PubMed ID: 25447226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
    Pappert EJ; Germanson T;
    Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered cerebellar-cerebral functional connectivity in benign adult familial myoclonic epilepsy.
    Long L; Zeng LL; Song Y; Shen H; Fang P; Zhang L; Xu L; Gong J; Zhang YC; Zhang Y; Zhou P; Huang S; Chen S; Xie Y; Hu D; Xiao B
    Epilepsia; 2016 Jun; 57(6):941-8. PubMed ID: 27037791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Botulinum Toxin on Network Connectivity in Cervical Dystonia: Lessons from Magnetoencephalography.
    Mahajan A; Alshammaa A; Zillgitt A; Bowyer SM; LeWitt P; Kaminski P; Sidiropoulos C
    Tremor Other Hyperkinet Mov (N Y); 2017; 7():502. PubMed ID: 29204314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KinesioTaping after botulinum toxin type A for cervical dystonia in adult patients.
    Dec-Ćwiek M; Porębska K; Sawczyńska K; Kubala M; Witkowska M; Zmijewska K; Antczak J; Pera J
    Brain Behav; 2022 Apr; 12(4):e2541. PubMed ID: 35238494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional activity of the sensorimotor cortex and cerebellum relates to cervical dystonia symptoms.
    Burciu RG; Hess CW; Coombes SA; Ofori E; Shukla P; Chung JW; McFarland NR; Wagle Shukla A; Okun MS; Vaillancourt DE
    Hum Brain Mapp; 2017 Sep; 38(9):4563-4573. PubMed ID: 28594097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum Toxin Type A Injection for Cervical Dystonia in Adults with Dyskinetic Cerebral Palsy.
    Yi YG; Kim K; Yi Y; Choi YA; Leigh JH; Bang MS
    Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29772695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical dystonia: factors deteriorating patient satisfaction of long-term treatment with botulinum toxin.
    Marciniec M; Szczepańska-Szerej A; Rejdak K
    Neurol Res; 2020 Nov; 42(11):987-991. PubMed ID: 32693754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type A and cervical dystonia: a seven-year follow-up.
    Camargo CH; Teive HA; Becker N; Munhoz RP; Werneck LC
    Arq Neuropsiquiatr; 2011 Oct; 69(5):745-50. PubMed ID: 22042174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebellum and cognition in progressive MS patients: functional changes beyond atrophy?
    Cocozza S; Pontillo G; Russo C; Russo CV; Costabile T; Pepe A; Tedeschi E; Lanzillo R; Brescia Morra V; Brunetti A; Inglese M; Petracca M
    J Neurol; 2018 Oct; 265(10):2260-2266. PubMed ID: 30056570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.